1-[2-(3-Bromo-phenyl)-propyl]-piperidine, 95.0%, 1g

4-Bromo-5-isopropyl-1H-pyrazole, 95.0%, 1g

(R)-4-((S)-1-Fluoroethyl)-3-(2-fluoropyrimidin-4-yl)oxazolidin-2-one, 97%, 100mg

5-Methyl-2-oxo-1,3-dioxane-5-carboxylic acid, 98%, 1g

1-N-Boc-2-Methylpropane-1,2-diamine hydrochloride, 95.0%, 250mg

5-Chloro-2-(methylsulfonyl)pyrimidine-4-carboxylic acid, 95.0%, 100mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(1-(tert-butoxycarbonyl)piperidin-4-yl)butanoic acid, 97%, 1g

9-hydroxy-9-azabicyclo[3.3.1]nonane, 97, 250mg

6-Bromo-4-hydroxycoumarin>98.0%(GC)(T)5g

4-((4-Bromo-2-fluorophenyl)amino)-6-methoxyquinazolin-7-ol, 95.0%, 5g

Tarros de boca ancha Vidrio transparente, 500 ml, GL 55, 20 Unidad(es)

4H,5H,6H,7H-pyrazolo[1,5-a]pyrazine hydrochloride, 95.0%, 5g

3-(TERT-BUTYL)-8-CHLORO-1-IODOIMIDAZO[1,5-A]PYRAZINE, 95.0%, 500mg